180x180pixels_CMA.jpg
OptimizeRx to Acquire Digital Therapeutics SaaS Platform Provider, RMDY Health
05 sept. 2019 10h30 HE | OptimizeRx Corporation
ROCHESTER, Mich., Sept. 05, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX) to acquire RMDY Health, a multipurpose digital therapeutics SaaS platform, for $16 million in cash and equity....
180x180pixels_CMA.jpg
OptimizeRx to Participate at Lake Street Annual Best Ideas Growth Conference on September 12, 2019
29 août 2019 08h31 HE | OptimizeRx Corporation
ROCHESTER, Mich., Aug. 29, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to participate...
180x180pixels_CMA.jpg
OptimizeRx Reports Record Second Quarter 2019 Results; Total Revenue Up 37% to $7.0 Million, Net Income up 45% to $407,000 or $0.03 per Diluted Share
07 août 2019 16h01 HE | OptimizeRx Corporation
ROCHESTER, Mich., Aug. 07, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the second...
180x180pixels_CMA.jpg
OptimizeRx Sets Second Quarter 2019 Conference Call for Wednesday, August 7, 2019 at 4:30 p.m. ET
24 juil. 2019 16h01 HE | OptimizeRx Corporation
ROCHESTER, Mich., July 24, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading platform for digital health messaging in the pharmaceutical industry, will hold a conference call on...
180x180pixels_CMA.jpg
OptimizeRx Establishes Direct Partnership and Integration with NextGen Healthcare
23 juil. 2019 08h31 HE | OptimizeRx Corporation
ROCHESTER, Mich., July 23, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading platform for digital health messaging in the pharmaceutical industry, announced a new partnership and...
180x180pixels_CMA.jpg
OptimizeRx Set to Join Russell Microcap® and 3000® Indexes
25 juin 2019 08h31 HE | OptimizeRx Corporation
ROCHESTER, Mich., June 25, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp.  (Nasdaq: OPRX), a leading platform for digital health messaging in the pharmaceutical industry, is expected to join the Russell...
180x180pixels_CMA.jpg
OptimizeRx to Participate at the 5th Annual ROTH London Conference on June 17-19, 2019
12 juin 2019 08h31 HE | OptimizeRx Corporation
ROCHESTER, Mich., June 12, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading platform for digital health messaging in the pharmaceutical industry, has been invited to participate...
180x180pixels_CMA.jpg
OptimizeRx Launches New Growth Phase Immediately Following Addition of Chief Commercial Officer
10 juin 2019 08h31 HE | OptimizeRx Corporation
ROCHESTER, Mich., June 10, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading platform for digital health messaging in the pharmaceutical industry, has added three senior sales...
180x180pixels_CMA.jpg
OptimizeRx Announces Pricing of Public Offering of Common Stock
05 juin 2019 08h50 HE | OptimizeRx Corporation
ROCHESTER, Mich., June 05, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, today announced the pricing...
180x180pixels_CMA.jpg
OptimizeRx Announces Proposed Public Offering of Common Stock
04 juin 2019 16h01 HE | OptimizeRx Corporation
ROCHESTER, Mich., June 04, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, today announced a proposed...